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Abstract
Heteroresistance in Cryptococcus neoformans is an intrinsic adaptive resistance to azoles and the heteroresistant phenotype
is associated with disomic chromosomes. Two chromosome 1 (Chr1) genes, ERG11, the fluconazole target, and AFR1, a drug
transporter, were reported as major factors in the emergence of Chr1 disomy. In the present study, we show Chr4 to be the
second most frequently formed disomy at high concentrations of fluconazole (FLC) and characterize the importance of
resident genes contributing to disomy formation. We deleted nine Chr4 genes presumed to have functions in ergosterol
biosynthesis, membrane composition/integrity or drug transportation that could influence Chr4 disomy under FLC stress. Of
these nine, disruption of three genes homologous to Sey1 (a GTPase), Glo3 and Gcs2 (the ADP-ribosylation factor GTPase
activating proteins) significantly reduced the frequency of Chr4 disomy in heteroresistant clones. Furthermore, FLC resistant
clones derived from sey1Dglo3D did not show disomy of either Chr4 or Chr1 but instead had increased the copy number of
the genes proximal to ERG11 locus on Chr1. Since the three genes are critical for the integrity of endoplasmic reticulum (ER)
in Saccharomyces cerevisiae, we used Sec61ß-GFP fusion as a marker to study the ER in the mutants. The cytoplasmic ER was
found to be elongated in sey1D but without any discernable alteration in gcs2D and glo3D under fluorescence microscopy.
The aberrant ER morphology of all three mutant strains, however, was discernable by transmission electron microscopy. A
3D reconstruction using Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) revealed considerably reduced
reticulation in the ER of glo3D and gcs2D strains. In sey1D, ER reticulation was barely detectable and cisternae were
expanded extensively compared to the wild type strains. These data suggest that the genes required for maintenance of ER
integrity are important for the formation of disomic chromosomes in C. neoformans under azole stress.
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Introduction
Cryptococcosis is caused by two environmental basidiomycetous
yeasts, Cryptococcus neoformans and Cryptococcus gattii [1]. The
infection caused by both species is most commonly treated with
amphotericin B as an induction regimen followed by azoles for
long-term maintenance therapy [2]. Azole drugs target the
biosynthetic pathway of ergosterol that is an essential component
of the fungal membrane [2,3]. The ergosterol biosynthetic
pathway has been extensively characterized (for review see [2].
It is synthesized in the endoplasmic reticulum (ER) starting from
acetyl-CoA through a series of enzymes encoded by different ERG
genes [2]. The sterol is then delivered to the cell membrane via
both vesicular and non-vesicular routes [3,4].
Since its introduction in 1990, fluconazole (FLC) has been the
most widely used azole antifungal as a prophylactic regimen as
well as for maintenance therapy of yeast infections such as
candidiasis and cryptococcosis [5,6,7]. Long-term treatment with
FLC results in the emergence of drug resistance strains. The
mechanism of FLC resistance has been well characterized in the
pathogenic yeast, Candida albicans (for review see [8,9,10].
Mutations or over-expression of enzymes in the ergosterol
synthetic pathway [11,12,13,14] or efflux pumps [15,16,17,18]
are known to be major causes in the emergence of azole resistant
strains. Since the number of drug resistant cases reported in
cryptococcosis patients has been much less than in candidiasis
patients, the mechanism of drug resistance in C. neoformans has not
been widely investigated. Like in other fungi, a mutation in ERG11
was reported from an azole resistant clinical strain and over
expression of the ABC transporter, AFR1 was reported to cause
resistance to FLC in a strain of C. neoformans constructed in the
laboratory [19,20].
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‘heteroresistance’ was reported in both serotype A and D strains of
C. neoformans isolated from patients in Italy and Israel [21].
Recently, the heteroresistance was reported to be an intrinsic
mechanism of adaptive resistance to triazoles in every strain of C.
neoformans and C. gattii [21,22,23]. The phenomenon of hetero-
resistance was characterized as the emergence of minor subpop-
ulations within a single colony of the susceptible strain that could
adapt to FLC concentrations higher than the strain’s minimum
inhibitory concentration (MIC). The acquired resistance in these
subpopulation is lost upon release from drug stress [23]. The
lowest concentration of FLC at which resistant subpopulation
emerges was defined as the level of heteroresistance to fluconazole
(LHF) of each strain. The FLC resistant subpopulations that
emerged at the LHF (32 mg/ml) for the genome sequenced strain
H99 were found to mostly contain disomic Chr1 [24]. As the FLC
concentration was elevated, however, additional disomies were
observed for Chr4, at 64 mg/ml and Chr10, Chr14 [24] and Chr3
at 128 mg/ml [unpublished data]. The extra copies of Chr1 and
Chr4 formed in response to azole stress were lost upon daily
transfer in drug free media [24]. Chr1 contains two genes known
to be involved in azole resistance in C. neoformans, ERG11, the
target of fluconazole, and AFR1, a drug transporter [24]. Elevation
of the dosage of these genes as a result of the disomy appears to
have enabled the strains to overcome the drug stress.
Apart from these two genes, factors mandating disomy
formations of the other chromosomes have yet to be identified.
Here, we show that Chr4 is another chromosome most frequently
found to be disomic at drug concentrations higher than the LHF.
We focused on the identification of Chr4 genes which contribute
to the strains’ drug resistance and necessitate formation of disomy
at higher concentration of FLC. Chr4 of C. neoformans does not
contain genes that are involved in ergosterol biosynthesis but does
contain two ABC transporters and a homolog of PDR16. Deletion
of the two ABC transporters had no effect on azole resistance
while deletion of PDR16 reduced the level of azole resistance.
Interestingly, PDR16 did not play a significant role in Chr4 disomy
formation. However, genes on Chr4 which are required for
maintenance of the endoplasmic reticulum (ER) integrity were
found to affect disomy formation under FLC stress.
Results
High frequency of Chr4 disomy at elevated
concentrations of FLC
The heteroresistance phenotype was identified as a fraction of
the cell population that could grow on media containing a
concentration of FLC that is higher than the strain’s MIC [23].
For convenience, in this report we have defined the first level of
heteroresistance to FLC (1LHF) as the lowest concentration of
FLC at which minor resistant subpopulations emerge. We used
arbitrary 2-fold increments of FLC concentration to define the
subsequent LHF’s. For instance, the 1LHF of the wild type strain
H99 is 32 mg/ml at which Chr1 is disomic in a majority of the
clones [24]. In the previous study, disomies of Chr1 and Chr4
were most commonly found in H99 at the second LHF (2LHF,
64 mg/ml) while those other chromosomes such as Chr10 and 14
were observed disomic at 128 mg/ml FLC (3LHF) [24]. We have
examined several independent FLC resistant clones of the H99
strain derived from 2LHF and 3LHF to determine the frequency
at which these chromosomes were duplicated in response to FLC
stress. By using the quantitative real time PCR (qPCR) to
determine copy-number of the genes, we found 100% of the 9
FLC resistant clones isolated from 2LHF contained disomic Chr1
while 55% of these clones also contained disomic Chr4 (data not
shown). At 3LHF, Chr1 was consistently duplicated in every clone
while Chr4 was the second most frequently duplicated chromo-
some in the 16 independent FLC resistant clones (82%) (Figure 1).
This suggests an importance of the Chr4 disomy for the survival of
C. neoformans at very high concentrations of FLC.
Identification of the genes potentially attributable to
formation of Chr4 disomy under fluconazole stress
One likely reason for the occurrence of Chr4 disomy in strains
resistant to high FLC concentrations is that some genes located on
Chr4 play an important role in azole resistance and an increase in
their copy number enhances tolerance for elevated azole stress. To
address this hypothesis, we screened annotated genes on Chr4 and
selected total nine genes that are likely to be non-essential and are
associated with drug resistance. The nine genes selected and
deleted were in two categories: 1) Genes reported to be important
for antifungal resistance included: the putative ABC transporters
(CNAG_07799 and CNAG_05150) [25], homolog of PDR16
(pleiotropic drug resistance, CNAG_04984) [26]; 2) Since FLC is
known to perturb the cell membrane, the second category
included those genes functionally associated with ergosterol
synthesis or membrane composition/integrity included: LRO1
(diacylglycerol acyltransferase, CNAG_05152) [27], TLK1 (phos-
phatidylinositol 3 kinase, CNAG_05220) [28,29], SEY1 (GTPase
with a role in ER morphology, CNAG_05124) [30], SLC1 (1-acyl-
sn-glycerol-3-phosphate acyltransferase, CNAG_05247) [31], and
GCS2 and GLO3 (ADP-ribosylation factor GTPase activating
proteins, CNAG_05050 and CNAG_05314) [32], respectively. No
known homologs of ERG genes are present on Chr4.
We first examined the importance of these genes in FLC
tolerance by spot assays on FLC containing media. We
determined homologs of SEY1 and GLO3 to be important for
FLC tolerance since deletion of sey1 and glo3 resulted in the
decrease of 1LHF (the lowest level of FLC at which heteroresistant
clones emerge) from 32 mg/ml to 16 mg/ml (Figure 2). As
observed in Candida albicans [33], disruption of PDR16 compro-
mised the ability of cells to tolerate FLC at 16 mg/ml (Figure 2).
Unlike AFR1, the ABC transporter on Chr1 that exerts a major
Figure 1. Chr4 disomy is associated with survival of C.
neoformans at high concentrations of FLC. 16 resistant clones
grown at 128 mg/ml FLC (3LHF) were randomly selected and the
numbers of each chromosome in the genome were estimated by
measuring the copy number of the genes specific to each chromosome.
The histogram displays the percentage of presumed disomy for each
chromosome in the 16 clones.
doi:10.1371/journal.pone.0033022.g001
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did not affect FLC tolerance (Figure 2). Furthermore, deletion of
the other five genes also did not affect FLC tolerance in H99.
Double deletions of SEY1 and GLO3, functionally redundant with
GCS2, resulted in a more severe susceptibility to FLC in which
1LHF was decreased to 8 mg/ml compared to 32 mg/ml in H99.
(Figure 2 and Table 1). Since several attempts to generate a double
deletant of gcs2Dglo3D failed, It is possible that deletion of these
two genes which encoding proteins associated with ER trafficking
is lethal in C. neoformans as is the case in S. cerevisiae [32]. The wild
type level of FLC tolerance was restored in all susceptible mutants
complemented with the wild type genes (Figure S1).
Deletion of genes encoding the proteins required for
maintenance of ER morphology and trafficking affects
the frequency of Chr4 disomy formation
Since glo3D, sey1D and pdr16D showed a reduction in FLC
tolerance, we studied the effect of each gene deletion in the disomy
formation of Chr4. Furthermore, since Chr4 disomy was more
frequently detected at 3LHF in H99 (Figure 1), we analyzed clones
from each of the deletant that emerged at 3LHF. Quantitative
PCR was carried out using probes specific for genes on each
chromosome to evaluate the status of presumed Chr4 disomy.
Interestingly, only one among 11 FLC resistant clones (9%)
derived from sey1D and 50% in glo3D (6/12) expressed a presumed
disomy of Chr4 while it was 82% (9/11) in the wild type strain and
73% (8/11) in the pdr16D strain (Figure 3). Furthermore, deletion
of the ABC transporters had no affect the Chr4 disomy formation
(data not shown). Unexpectedly, in 3 of the 11 FLC resistant
clones (27%) derived from sey1D did not show disomies of either
Chr1 or Chr4 (Type 3 in Figure 3, Type 1 denotes strains that
contain Chr1 and Chr4 disomy, Type 2 denotes strains that
contain Chr1 disomy only, Type 3 denotes strains that do not
contain disomies of either Chr1 or Chr4). The clones that did not
contain disomies of either Chr1 or Chr4 (Type 3) showed similar
comparative genome hybridization (CGH) patterns for all
chromosomes as the wild type. The Type 3 clones were most
likely the result of mutation(s) at other loci relevant for drug
resistance since they remained resistant to FLC despite continuous
passages in drug free media for 3 months (data not shown).
Although deletion of GCS2, a gene on Chr4 that shares a
function similar to that of GLO3 in other organisms [32,34], did
not affect FLC tolerance but only 2 of 8 gcs2D derived FLC
resistant clones (25%) showed disomic Chr4 (Figure 3). Interest-
ingly, all FLC resistant clones derived from the double deletants of
sey1Dglo3D lacked Chr4 disomy (Figure 3). Since the classification
of three types based on disomic status of Chr1 and Chr4 was
Figure 2. Spot assay for FLC tolerance. Cells of the indicated
strains were spotted on YPD alone or YPD supplemented with either
8 mg/ml or 16 mg/ml FLC and incubated at 30uC for 5 days. Increase in
sensitivity to FLC was seen in strains containing disruptions of several
genes on Chr4 including, GLO3, SEY1 and PDR16.
doi:10.1371/journal.pone.0033022.g002
Table 1. List of strains and their levels of heteroresistance.
Strain Description Concentration of FLC at 1, 2 and 3LHF (mg/ml)
H99 wild type 32, 64, 128
gcs2D ADP-ribosylation factor GTPase activating protein 32, 64, 128
glo3D ADP-ribosylation factor GTPase activating protein 16, 32, 64
sey1D GTPase interacts with ER-shaping protein 16, 32, 64
sey1Dglo3D double deletion of SEY1 and GLO3 8, 16, 32
abc1D ATP binding cassette transporter 32, 64, 128
abc2D ATP binding cassette transporter 32, 64, 128
pdr16D pleiotropic drug resistance 16, 32, 64
lro1D diacylglycerol acyltransferase 32, 64, 128
slc1D 1-acyl-sn-glycerol-3-phosphate acyltransferase 32, 64, 128
tlk1D PIK-related protein kinase 32, 64, 128
gcs2D::GCS2* homologous complementation with GCS2 32, 64, 128
glo3D::GLO3 homologous complementation with GLO3 32, 64, 128
sey1D::SEY1 homologous complementation with SEY1 32, 64, 128
sey1Dglo3D::SEY1 homologous complementation with SEY1 16, 32, 64
sey1Dglo3D::GLO3 homologous complementation with GLO3 16, 32, 64
sey1D,SEY1chr3 complementation to Chr3 with SEY1 32, 64, 128
glo3D,GLO3chr3 complementation to Chr3 with GLO3 32, 64, 128
*The GCS1 homolog of S. cerevisiae was named GCS2 as GCS1 has already been used to designate glucosylceramide synthase in C. neoformans [62].
doi:10.1371/journal.pone.0033022.t001
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clone from each type in every deletant to determine whether gene
duplication represented duplication of the entire chromosome
(Figure S2). The CGH results were consistent with qPCR data
except for the Type 1 clones derived from the double deletants (see
below). Furthermore, the original frequency of Chr4 disomy was
restored in sey1D, glo3D, and gcs2D mutants when reconstituted
with the respective wild type genes (Figure S3). These results
suggest that the genes that encode proteins required for putative
ER structure and trafficking affect Chr4 disomy formation in C.
neoformans.
Relocation of SEY1 and GLO3 to Chr3 increases the
frequency of Chr3 disomy
A correlation between the chromosomal location of genes
specifically important for azole resistance and disomy of the
corresponding chromosome has been shown in C. albicans and C.
neoformans [24,35]. For example, relocation of the ERG11 gene
from Chr1 to Chr3 in C. neoformans resulted in disomy of Chr3
instead of Chr1 at the 1LHF [24]. To determine a similar
importance of the SEY1 and GLO3 genes on chr4, we reconstituted
the sey1D and glo3D strains independently by inserting a wild type
copy of the respective genes into Chr3 instead of their native
location on Chr4. When clones resistant at 3LHF were analyzed,
the frequency of Chr3 disomy was significantly higher in both
reconstituted strains SEY1 and GLO3 compared to the wild type
strain (Figure 4). Interestingly, however, the frequency of Chr4
disomy in these strains was comparable to the wild-type strain.
Only a segment of Chr1 is duplicated in sey1D derived
double deletants
Based on the qPCR of genes present on Chr1 and Chr4 , Type2
FLC resistant clones derived from sey1Dglo3D only contained
disomy of chr1 (Figure 3). However, the CGH patterns observed
in these clones were unusual in that instead of the whole
chromosome being duplicated, there seem to have increased gene
dosage only at the chr1 region proximal to the ERG11 locus
(Figure 5). Interestingly, the region where gene duplication
Figure 3. Frequency of Chr4 disomy formation in deletants of
Chr4 genes. Clones resistant to 3LHF derived from each deletant were
isolated and the copy number of Chr1 and Chr4 in the genome was
inferred by assessing the copy number of the genes specific to each
chromosome by qPCR. The figure displays the percentage of each type
of disomy in the FLC resistant strains. Type1 denotes strains that
contain Chr1 and Chr4 disomy, Type2 denotes strains that contain Chr1
disomy, Type3 denotes strains that contain no disomic Chr1 or Chr4.
doi:10.1371/journal.pone.0033022.g003
Figure 4. Frequency of Chr3 disomy is increased in the strains
with SEY1 and GLO3 translocation to Chr3. The wild type genes
SEY1 and GLO3 were each inserted into Chr3 of the respective deletant
strains sey1D and glo3D. 6–8 resistance clones grown at 3LHF were
analyzed for copy number of the genes specific to each chromosome.
Each bar represents the frequency of disomy formation in each
chromosome.
doi:10.1371/journal.pone.0033022.g004
Figure 5. CGH analysis of the sey1Dglo3D double deletants
isolated from 3LHF. CGH was performed with genomic DNA
extracted from double deletants that showed Type 2 duplication
patterns at 3LHF in Figure 3. H99 and the resistant clones of H99 grown
at 3LHF were included as controls. Only the Chr1 status is shown. No
additional disomy was found in any of the clones except for the clone
from H99 at 3LHF (data not shown). Arrows indicate the location of
ERG11. Each bar represents the copy number of each gene residing on
Chr1 or 4 in log2 scale.
doi:10.1371/journal.pone.0033022.g005
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and no gene duplication was observed in any other chromosome
(data not shown). Furthermore, some of the clones had more than
two copies of ERG11. It is possible that the extra copies of the
Chr1 genes could have resulted from partial chromosome
duplication, gene duplication combined with chromosomal
translocation, or from an episomal event. To investigate the
chromosomal status of these clones, we examined their genome by
clamped homogeneous electric field (CHEF) gel analysis. One of
the clones (sey1Dglo3Db) clearly contained additional chromosomes
compared to the wild type (Figure 6A). However, using ERG11 as
a probe for the CHEF blot, the hybridization signal indicated that
ERG11 is localized only on Chr1 in sey1Dglo3Db and not on the
extra chromosomes. Two other double deletant clones did not
show any change in the chromosomal pattern. The ERG11 signal
was only detected in Chr1 of sey1Dglo3Da. Additionally, the ERG11
gene in the sey1Dglo3Dc clone was present on Chr1 as well as on
another chromosome (Figure 6B). Copy number of the ERG11
gene in each clone determined by CHEF blot quantitated by
phosphoimager agreed with the qPCR results (Figure 6C). This
result indicates that the increase in copy number demonstrated by
qPCR is not contributed by an episomal event. Therefore, the
genomic regions that contain the extra copies of ERG11 revealed
in CGH were likely to have resulted from a partial duplication of
Chr1 and/or a chromosomal translocation.
Deletants of the genes controlling ER morphogenesis
show variable degrees of aberration in ER morphology
Since SEY1, GLO3 and GCS2 are known to be important for ER
morphogenesis in other organisms [30,32,36,37], we thought it
was possible that deletants of these genes in C. neoformans may have
structural changes in ER. We constructed a GFP fusion with the C.
neoformans ER located protein, Sec61ß and used the construct to
monitor the ER morphology. Transformants of Sec61ß-GFP in
the wild type strain showed the GFP signal to be located near the
nuclear envelope and the element near the plasma membrane
connected with strands in the cytoplasm; a typical ER pattern as
seen in S. cerevisiae (Figure 7A) [38]. By contrast, the cytoplasmic
ER in the sey1D strain was elongated which was not the case in the
gcs2D and the glo3D strains. Elongation of the ER was also evident
in the double deletants of sey1Dglo3D (Figure 7A). The morpho-
logical differences of the ER between the wild type and the
deletant strains were better illustrated in the TEM where the
cytoplasmic ER was elongated in all the mutants compared to the
wild type strain (Figure 7B, arrows).
3D reconstruction using Focused Ion Beam-Scanning
Electron Microscope showed double deletants lost the
reticular structure of normal ER
Since ER in eukaryotic cells is a reticular structure [30,39]
which extends from the nuclear membrane into the cytoplasm, a
typical TEM section of the cells does not lend itself to visualization
of the whole ER structure in a three dimensional context. Thus,
we used the FIB-SEM technology to generate serial section views
for 3D reconstruction of cryptococcal cells. The wild type cells
showed the typical cisternae (continuous sheet) with reticular
structures extending throughout the cytoplasm in 3D (Figure 8).
Figure 6. Analysis of the ERG11 chromosomal location in the
Type2 sey1Dglo3D clones. A) CHEF gel analysis. Chromosomes of the
indicated strains were separated by CHEF and stained with ethidium
bromide. B) Southern blot analysis. DNA of the CHEF gel was
transferred to membrane and hybridized with ERG11 (Chr1) and
CNAG_06646 (Chr7) probes. Star indicates the non-Chr1 located
ERG11. C) Copy-number of ERG11. White bar indicates the copy number
of ERG11 from the CHEF quantified by phosphor-imager and the black
bar represents the copy number of ERG11 analyzed by qPCR. Gray
bar=non-Chr1 ERG11 indicates the copy number of ERG11 from the
CHEF quantified by phosphor-imager of the band marked with a star
from B). Error bar=2 SD.
doi:10.1371/journal.pone.0033022.g006
Figure 7. Disruption of SEY1, GCS2 and GLO3 causes ER
elongation. A) A GFP fusion of the ER protein Sec61bp was expressed
in each indicated strain. Cells from fresh overnight culture grown on
YPD agar at 30uC were visualized under a florescent microscope. White
arrow head=ER; grey arrow head=nucleus (determined by co-localized
Hoechst 3342 dye staining; Figure S4). B) Transmission Electron
Microscopy (TEM) of each deletant and the wild type cells. Cells were
grown overnight on a shaker at 30uC in YPD broth to mid log phase and
cells were prepared for and examined by TEM.
doi:10.1371/journal.pone.0033022.g007
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reticular ER structures. Most strikingly, in sey1D and sey1Dglo3D
cells, the reticular ER morphology was barely detectable and
formed mostly expanded cisternae distinct from the wild type
pattern (Figure 8). These data indicated that C. neoformans genes
SEY1, GLO3, and GCS2 are important for maintaining normal ER
morphology.
Discussion
The relationship between occurrence of aneuploidy and azole
resistance has been well documented in both pathogenic yeasts, C.
albicans [40] and C. neoformans [24]. Formation of either partial or
whole chromosome disomy has been shown to benefit the yeasts
for survival under azole stress [24,41]. In addition to the
importance of ERG11 and AFR1 for disomy formation in Chr1
for survival under azole stress in C. neoformans, we present here an
association between three genes that encode proteins involved in
ER trafficking and structural maintenance with formation of
disomy when stressed with high levels of FLC. Our results show
that disruptions of SEY1, GCS2, and GLO3 result in significantly
reduced frequencies of Chr4 disomy. Moreover, translocating
some of these genes to Chr3 increased the frequency of disomy
formation in Chr3 at high FLC levels.
Since formation of disomy is an energy consuming process and
its maintenance would be stressful for the cells, aneuploidy is
typically transient. Survival in a stressful environment such as that
presented by high drug concentrations, only cells that possess
either duplicated whole chromosomes or part of the chromosome
containing genes pertinent to drug resistance [42]. For example,
ERG11 which encodes the azole target protein is localized on Chr5
in C. albicans [35,40] and on Chr1 in C. neoformans [24] and these
chromosomes are found either duplicated partially or entirely in
the FLC resistant clones which emerged in response to azole stress.
We demonstrate here that a new set of genes related to ER
function play an important role in Chr4 disomy formation in C.
neoformans. Of the 9 Chr4 genes studied, the deletion of 2 of these
genes, sey1D and glo3D, resulted in higher susceptibility to FLC and
lower frequency of disomies. Although deletion of the GCS2 gene
did not alter the strain’s sensitivity to FLC, it did affect Chr4
disomy formation at high concentrations of FLC. Interestingly,
PDR16 was required for FLC resistance but did not have a
significant effect on the frequency of Chr4 disomy formation. This
suggests that Chr4 disomy formation does not solely depend on the
genes that affect FLC susceptibility. Moreover, the location of
genes on certain chromosomes influences the outcome of disomy
formation since translocation of SEY1 or GLO3 to Chr3 results in
an increase in the frequency of Chr3 disomy formation. However,
in spite of such relocation of one or the other gene, the frequency
of Chr4 disomy in these strains was maintained to wild type levels.
This suggests that SEY1 and GLO3 are equally important for
disomy of Chr4 and disomy of Chr4 is not dependent on the
location of SEY1 or GLO3 but rather the presence of functional
copies in the genome. Duplications of other Chr4 genes together
with either SEY1 or GLO3 appear to be beneficial for the survival
of C. neoformans under FLC stress.
Moreover, the influence of SEY1 and GLO3 on formation of
Chr4 disomy can be explained. The absence of either of the two
genes renders C. neoformans unable to resist FLC stress. Hence,
increase in the copy number of Chr4 genes resulting from disomy
would not enable C. neoformans to reach a resistance level required
to overcome the heightened drug stress. This explanation is
supported by the induction of Chr3 disomy as SEY1 and GLO3 are
relocated to Chr3. These results suggest that the elevated
expression of these genes resulting from increased copy number
is important for C. neoformans to tolerate azole stress. However, the
mechanism is probably more complicated since the deletion of
GCS2 genes also compromised Chr4 disomy formation without
significant perturbation of ER integrity or azole susceptibility and
warrants a further study.
The FIB-SEM study shows that the ER morphology is altered in
all three mutant strains. In particular, reticulation of the ER in the
double mutant sey1Dglo3D was greatly reduced and the cisternae
expanded significantly. These data suggest that SEY1, GLO3 and
GCS2 are important for the ER integrity. The involvement of
SEY1 and GLO3 in ER morphology has been demonstrated in
other systems. In S. cerevisiae, Sey1 is a GTPase and is involved in
the generation of the tubular ER network [30]. Glo3 is an ADP-
ribosylation factor GTPase activating proteins involved in ER-
Golgi transport which shares functional similarity with Gcs1p.
Double deletion of GLO3 and GCS1 (homolog of GCS2 in C.
neoformans) causes morphological aberrations under restricted
conditions [32,37]. Furthermore, in S. cerevisiae, GCS1 and GLO3
mediates Golgi-ER and post-Golgi vesicle [32,43,44]. Thus, we
tested functions of the two secreted cryptococcal virulence factors,
urease [45] and laccase [46]. No differences in secretion of the two
virulence factors were found among the mutants comparing to
H99 (Figure S5). This suggests that defects on vesicle transport of
those mutants are minimal. However, it is known that intact
protein transport between ER and Golgi is required for protein
glycosylation [47] and disruption of GLO3 or GCS1 impairs
glycosylation in S. cerevisiae [32]. This is also the case in C.
neoformans where disruption of either GLO3 or GCS1 causes
increases in sensitivity to tunicamycin (a N-glycosylation inhibitor
Figure 8. The FIB-SEM showed all mutants to have variable
degrees of aberration in ER morphology. Left column shows
orthoslices representing central slices through the volume. 3D
reconstructions of the ER in indicated strains were generated from
data collected by serial 3–10 nm cuts of each sample through the cell.
ER and nuclei were psuedo-colored with green and blue color,
respectively. The FIB-SEM picture of H99 was taken at different angle
from the orthoslice to have a clearer view of the ER structure.
doi:10.1371/journal.pone.0033022.g008
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required for both mitosis [50] and cytokinesis [51] but N-
glycosylation has not been reported to be associated with mitosis.
How N-glycosylation is associated with disomy formation remains
unexplained and need further study.
Although disomy formation was observed in Chr4 and other
chromosomes, Chr1 was the only chromosome consistently found
to be duplicated at high levels of FLC in all our studies. This could
be due to the selection for survival under FLC stress where
ERG11/AFR1 duplication enables the strains to effectively tolerate
high FLC concentrations. Interestingly, we observed that the FLC
resistant clones derived from sey1Dglo3D double deletions failed to
produce duplication of the entire chromosome, but only caused a
partial duplication of the chromosome region proximal to ERG11
locus. These results underscore the importance of the ERG11 gene
and the necessity of ER structural integrity for the survival of C.
neoformans under FLC stress.
Despite discoveries of disomy/isochromosome formation as a
novel mechanism of azole resistance in pathogenic fungi [24,40],
the mechanism by which azoles cause such a phenomena remains
unknown. Here, our results shed some light on the relationship
between impairment of ER integrity and chromosome disomy
formation under FLC treatment. Since FLC targets synthesis of
ergosterol essential for fungal cells and the sterol is synthesized in
ER before being delivered to the plasma membrane via both
vesicular and non-vesicular routes [3,4], it is conceivable that
alterations in ER integrity would affect the survival of cells under
FLC stress. But, how does ER influence disomy formation? The ER
in eukaryotic cells is a dynamic and continuous membrane network
consisting of interconnected cisternae and tubules in direct contact
with the nuclear envelope, which stretches throughout the cytosol
[39,52]. In fact, the ER may influence mitosis through its
interconnection with the nuclear envelope [52,53,54] which in turn
controls chromosomal segregation through its association with the
spindle pole body [55]. Furthermore, it has been shown that
alterations of ER conformation could rescue the defect of nuclear
envelope breakage in pim1D and allowed the cells to survive through
mitosis [53]. Hence, disruption of ER function, such as glycosyl-
ation, combined with drastic change in ER structure may interfere
with the normal pattern of chromosomal segregation and
subsequently thwart chromosomal disomy formation. However,
the mechanisms of how ER function/structure influence such
events remains unclear and further studies are warranted to resolve
this important question of cell biology.
Materials and Methods
Strains and Media
All deletants were constructed in the C. neoformans H99
background [56] and are listed in Table 1. All strains were
maintained on non-selective YPD agar (1% yeast extract, 2%
peptone, 2% glucose, 2% agar). YPD supplemented with 8, 16, 32,
64, or 128 mg/ml FLC or 125 ng/ml tunicamycin were used to
study phenotypes of the deletants. Melanin and urease induction
media was prepare according to a standard protocol [57]. For spot
assays, 2 ml of a cell suspension with an optical density at 600 nm
(OD600) of 2 to 3 or more 10-fold dilutions were spotted on YPD
agar with or without the drugs. The plates were incubated at 30uC
for 3–5 days and photographed.
Gene manipulations
Annotated genes on Chr4 were selected from the H99
genome database (http://www.broadinstitute.org/annotation/
genome/cryptococcus_neoformans/MultiHome.html). Genes of
interest were disrupted by biolistic transformation [58]. Briefly,
disruption constructs were created by overlapping PCR technique
[59] or vector cloning linked with Nourseothricin (NAT1), G418
(NEO) or Hygromycin (HGR) resistance genes as dominant
selectable markers. Then, the constructs were transformed into
the H99 cells by a Bio-Rad model PDS-1000/He biolistic particle
delivery system. Homologous integrations were confirmed by PCR
and Southern hybridization. Complementation of each deletant
was accomplished by homologous integration at the deleted locus
or reintroduced to a specific location on Chr3 as described
previously [24]. Primers for overlapping PCR and vector cloning
are listed in Table S1.
Quantitation of gene dosage
Quantitative real time PCR (qPCR) assays were performed to
quantitate the gene copy number on specific chromosomes in wild-
type, deletants and FLC-resistant strains as previously described
[24]. 6–16 independent clones of each strain were tested.
Comparative Genome Hybridization (CGH)
Genomic DNA was extracted using overnight culture in YPD as
described previously [24]. DNA labeling was performed by
BioPrimeHArray CGH Genomic Labeling System Kit (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instruction. Briefly,
genomicDNAwas digested byDpnII(NewEnglandBiolabs,Ipswich,
USA). Alexa647 and Alexa555 dye were labeled to the experimental
and control samples, respectively. Subsequently, the labeled samples
were hybridized to JEC21-based 70mer slides (http://genome.wustl.
edu/services/microarray/cryptococcus_neoformans) and analyzed
as previously described [24].
Clamped homogeneous electric field (CHEF) gel
electrophoresis
Cells were grown on YPD agar with or without FLC for 2–3
days. Cells were harvested from the plate and dilute to 2.0 OD600
in 10 ml of 10% b-mercaptoethanol and incubate at 37uC for
30 min. Cells were pelleted and resuspended in 1 ml of
spheroplasting solution (1 M sorbitol, 10 mM EDTA, 100 mM
sodium citrate, pH5.8) mixing with 300 mg/ml Vinoflow FCE
(Novozymes, Bagsvaerd, Denmark) and incubated at 30uC for
1.5 hr with gentle shaking. After pelleting the cells by spinning at
700 g for 10 min and washing twice with cold spheroplasting
solution, cells were resuspended in 150 ml of the spheroplasting
solution. Gel preparation and electrophoresis condition were
performed according to a previous study [60]. Subsequently,
Southern hybridization was performed using
32P labeled probes of
ERG11 and the promoter region of CNAG_ 06646 on Chr7 which
is proven not to form disomy by CGH of any strain in this study
(data not shown). After hybridization, the membranes were
exposed to a phospho-imager screen and signals were quantified
with ImageQuant (Molecular Dynamics). The relative copy
number of each gene was obtained by comparing the signal
intensity of the experimental probe, ERG11, to that of the internal
control probe, CNAG_ 06646.
Fluorescence microscopy
To visualize ER in the yeast, an ER-protein Sec61b/Sbh1
homolog, CNAG_06351, was identified through BlastP implement-
ed in the H99 genome website and tagged with GFP [30]. A
construct of Sec61b-GFP was cloned and transformed into
indicated strains by biolistic transformation. The GFP signals
were visualized for ER morphology under the fluorescence Zeiss
Axiovert microscope and Axiovision (version 4.0) software.
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Cells were prepared and stained according to a previous
publication [61]. Briefly, cells were grown in YPD broth overnight,
diluted and transferred to fresh YPD and grown to mid-log phase.
Cells were harvested and washed once in 1 ml of primary fixative
(0.1 M sorbitol, 1 mM MgCl2, 1 mM CaCl2, 2% glutaraldehyde
in 0.1 M PIPES buffer, pH 6.8). Then, cells were resuspended in
the fixative. Cells were post-fixed with 2% KMnO4, dehydrated
with a graded ethanol series and propylene oxide prior to
infiltrating and embedding in Epon. Cells were prepared for
visualization of membrane structures under transmission electron
microscope (TEM) according to the method described [61].
Briefly, the fixed samples were sectioned using a Leica UC6 (Leica
Microsystems, Vienna, Austria) and viewed on a Hitachi H-7500
(Hitachi, Tokyo, Japan) at 80 kV. Digital images were obtained
with a Hammamatsu XR-100 digital camera system (AMT,
Danvers, MA.)
Focused Ion Beam-Scanning Electron Microscopy (FIB-SEM)
Using the same sample preparation technique noted above,
specimens were mounted into the FIB-SEM. All data sets were
collected on a FEIHelios NanoLab 650 DualBeam
TMequipped with
Ga
+ LMIS FIB used for milling (FEI, Hillsboro, OR).Prior to milling
a protective platinum cap was deposited on the area of interest and
3–10 nm cuts weremade.To perform milling operation, the FIB was
setto30 keVandabeamcurrentof790pAwasemployed.Thepixel
sizes and horizontal field width for each data set are as follows:
12 mm; sey1Dglo3D 3n m 63n m 65n m , 1 3mm; 20.4 mm; H99,
sey1D, glo3D,a n dgcs2D 10 nm610 nm610 nm, 20.4 mm. All
imaging was done at 2 keV and 200 pA. A BSE signal was collected
with brightness and contrast inverted. Data was aligned using the
Amira Visualization Package (version 5.3.3, Visage Imaging,
Carlsbad, CA). Data was binned by 4 with the IMOD software
package (version 4.2.10, University of Colorado Boulder, Boulder,
CO) and all 3-D surface models were created from unfiltered images
by manually selecting areas of interest and smoothing the 3-D
volumes using Amira.
Supporting Information
Figure S1 Spot assay. Cell suspensions of each indicated strain
were spotted on different media and incubated at 30uC for 5 days.
Reconstitution of the deletants by the wild type gene restored their
susceptibility to FLC. sg=sey1Dglo3D.
(TIF)
Figure S2 CGH analysis of disomy formation in each
type. Type1=disomy of Chr1 and Chr4, Type2=disomy of
Chr1 only, Type3=no disomy of either Chr1 or Chr4. Each panel
is representative of the CGH result from each disomy type. Only
the status of Chr1 and Chr4 copy number is shown. The CGH
data is consistent with the qPCR results except for the double
mutant. Each bar represents the copy number of each gene
residing on Chr1 or 4 in log2 scale.
(TIF)
Figure S3 The frequency of Chr4 disomy formation is
restored in each mutant reconstituted with the wild type
gene. Clones of each complemented strain resistant at 3LHF were
isolated and their Chr1 and Chr4 copy numbers were inferred by
analyzing dosage of the genes specific to each chromosome by
using qPCR. The figure displays the frequency of each f disomy
type among the FLC resistant strains. Type1 denotes strains that
contain disomies of Chr1 and Chr4, Type2 denotes strains that
contain disomy of Chr1 only, and Type3 denotes strains
containing no disomies of either Chr1 or Chr4.
(TIF)
Figure S4 ER structure of H99. A GFP fusion of the ER
protein Sec61bp was expressed in the wild type. Cells from fresh
overnight culture grown on YPD agar at 30uC were visualized
under a florescent microscope. Nucleus is determined by co-
localized Hoechst 3342 dye staining giving blue color. (From left to
right; GFP, Hoechst 3342 staining, merge, DIC).
(TIF)
Figure S5 Ability to produce urease and melanin was
unchanged in all mutants. Cell suspensions of each indicated
strain were spotted on melanin (A) and urease (B) test media and
incubated at 30uC for 2 days.
(TIF)
Figure S6 Disruption of GCS2 and GLO3 increased
sensitivity to tunicamycin, an ER perturbing agent. Cells
suspensions were serially diluted 10-fold from a stock at OD600=2
and spotted on YPD agar plates with or without 125 ng/ml
tunicamycin. Plates were incubated at 30uC for 3 days.
(TIF)
Table S1 Primers used.
(DOCX)
Acknowledgments
We thank A. Varma for critical discussions and reading of the manuscript.
Author Contributions
Conceived and designed the experiments: PN YC KJK. Performed the
experiments: PN BH CB. Analyzed the data: PN YC BH CB EF KJK.
Contributed reagents/materials/analysis tools: CB EF KJK. Wrote the
paper: PN YC BH EF KJK.
References
1 . K w o n - C h u n gK J ,S o r r e l lT C ,D r o m e rF ,F u n gE ,L e v i t zS M( 2 0 0 0 )
Cryptococcosis: clinical and biological aspects. Med Mycol 38 Suppl 1: 205–213.
2. Akins RA (2005) An update on antifungal targets and mechanisms of resistance
in Candida albicans. Med Mycol 43: 285–318.
3. Sullivan DP, Ohvo-Rekila H, Baumann NA, Beh CT, Menon AK (2006) Sterol
trafficking between the endoplasmic reticulum and plasma membrane in yeast.
Biochem Soc Trans 34: 356–358.
4. Schulz TA, Prinz WA (2007) Sterol transport in yeast and the oxysterol binding
protein homologue (OSH) family. Biochim Biophys Acta 1771: 769–780.
5. Washton H (1989) Review of fluconazole: a new triazole antifungal agent. Diagn
Microbiol Infect Dis 12: 229S–233S.
6. Brion LP, Uko SE, Goldman DL (2007) Risk of resistance associated with
fluconazole prophylaxis: systematic review. J Infect 54: 521–529.
7. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, et al. (2010)
Clinical practice guidelines for the management of cryptococcal disease: 2010
update by the infectious diseases society of america. Clin Infect Dis 50: 291–322.
8. Martinez M, Lopez-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, et al.
(2002) Heterogeneous mechanisms of azole resistance in Candida albicans clinical
isolates from an HIV-infected patient on continuous fluconazole therapy for
oropharyngeal candidosis. J Antimicrob Chemother 49: 515–524.
9. Perea S, Lopez-Ribot JL, Kirkpatrick WR, McAtee RK, Santillan RA, et al.
(2001) Prevalence of molecular mechanisms of resistance to azole antifungal
agents in Candida albicans strains displaying high-level fluconazole resistance
isolated from human immunodeficiency virus-infected patients. Antimicrob
Agents Chemother 45: 2676–2684.
10. Shapiro RS, Robbins N, Cowen LE (2011) Regulatory circuitry governing fungal
development, drug resistance, and disease. Microbiol Mol Biol Rev 75: 213–267.
11. Favre B, Didmon M, Ryder NS (1999) Multiple amino acid substitutions in
lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
Microbiology 145(Pt 10): 2715–2725.
12. Morio F, Loge C, Besse B, Hennequin C, Le Pape P (2010) Screening for amino
acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and
Chromosome 4 Disomy Formation in C. neoformans
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33022azole-resistant clinical isolates: new substitutions and a review of the literature.
Diagn Microbiol Infect Dis 66: 373–384.
13. Bard M, Lees ND, Turi T, Craft D, Cofrin L, et al. (1993) Sterol synthesis and
viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in
Saccharomyces cerevisiae and Candida albicans. Lipids 28: 963–967.
14. Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, et al. (1999)
Contribution of mutations in the cytochrome P450 14alpha-demethylase
(Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145(Pt
10): 2701–2713.
15. Prasad R, De Wergifosse P, Goffeau A, Balzi E (1995) Molecular cloning and
characterization of a novel gene of Candida albicans, CDR1, conferring multiple
resistance to drugs and antifungals. Curr Genet 27: 320–329.
16. Chen LM, Xu YH, Zhou CL, Zhao J, Li CY, et al. (2010) Overexpression of
CDR1 and CDR2 genes plays an important role in fluconazole resistance in
Candida albicans with G487T and T916C mutations. J Int Med Res 38: 536–545.
17. Sanglard D, Ischer F, Monod M, Bille J (1997) Cloning of Candida albicans genes
conferring resistance to azole antifungal agents: characterization of CDR2, a new
multidrug ABC transporter gene. Microbiology 143(Pt 2): 405–416.
18. Gupta V, Kohli A, Krishnamurthy S, Puri N, Aalamgeer SA, et al. (1998)
Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of
Candida albicans which confers multidrug resistance, and its in vitro transcrip-
tional activation. Curr Genet 34: 192–199.
19. Rodero L, Mellado E, Rodriguez AC, Salve A, Guelfand L, et al. (2003) G484S
amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to
fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Antimicrob Agents Chemother 47: 3653–3656.
20. Posteraro B, Sanguinetti M, Sanglard D, La Sorda M, Boccia S, et al. (2003)
Identification and characterization of a Cryptococcus neoformans ATP binding
cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to
fluconazole. Mol Microbiol 47: 357–371.
21. Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, et al. (1999)
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Antimicrob Agents Chemother 43: 1856–1861.
22. Varma A, Kwon-Chung KJ (2010) Heteroresistance of Cryptococcus gattii to
fluconazole. Antimicrob Agents Chemother 54: 2303–2311.
23. Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ (2009) Heteroresistance
to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
Antimicrob Agents Chemother 53: 2804–2815.
24. Sionov E, Lee H, Chang YC, Kwon-Chung KJ (2010) Cryptococcus neoformans
overcomes stress of azole drugs by formation of disomy in specific multiple
chromosomes. PLoS Pathog 6: e1000848.
25. Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, et al. (2009) Efflux-
mediated antifungal drug resistance. Clin Microbiol Rev 22: 291–321, Table of
Contents.
26. van den Hazel HB, Pichler H, do Valle Matta MA, Leitner E, Goffeau A, et al.
(1999) PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect
lipid biosynthesis and resistance to multiple drugs. J Biol Chem 274: 1934–1941.
27. Oelkers P, Tinkelenberg A, Erdeniz N, Cromley D, Billheimer JT, et al. (2000) A
lecithin cholesterol acyltransferase-like gene mediates diacylglycerol esterifica-
tion in yeast. J Biol Chem 275: 15609–15612.
28. Davidson RC, Blankenship JR, Kraus PR, de Jesus Berrios M, Hull CM, et al.
(2002) A PCR-based strategy to generate integrative targeting alleles with large
regions of homology. Microbiology 148: 2607–2615.
29. Beck T, Hall MN (1999) The TOR signalling pathway controls nuclear
localization of nutrient-regulated transcription factors. Nature 402: 689–692.
30. Hu J, Shibata Y, Zhu PP, Voss C, Rismanchi N, et al. (2009) A class of dynamin-
like GTPases involved in the generation of the tubular ER network. Cell 138:
549–561.
31. Athenstaedt K, Daum G (1997) Biosynthesis of phosphatidic acid in lipid
particles and endoplasmic reticulum of Saccharomyces cerevisiae. J Bacteriol 179:
7611–7616.
32. Poon PP, Cassel D, Spang A, Rotman M, Pick E, et al. (1999) Retrograde
transport from the yeast Golgi is mediated by two ARF GAP proteins with
overlapping function. EMBO J 18: 555–564.
33. Saidane S, Weber S, De Deken X, St-Germain G, Raymond M (2006) PDR16-
mediated azole resistance in Candida albicans. Mol Microbiol 60: 1546–1562.
34. Lettner T, Zeidler U, Gimona M, Hauser M, Breitenbach M, et al. (2010)
Candida albicans AGE3, the ortholog of the S. cerevisiae ARF-GAP-encoding gene
GCS1, is required for hyphal growth and drug resistance. PLoS One 5: e11993.
35. Selmecki A, Gerami-Nejad M, Paulson C, Forche A, Berman J (2008) An
isochromosome confers drug resistance in vivo by amplification of two genes,
ERG11 and TAC1. Mol Microbiol 68: 624–641.
36. Brands A, Ho TH (2002) Function of a plant stress-induced gene, HVA22.
Synthetic enhancement screen with its yeast homolog reveals its role in vesicular
traffic. Plant Physiol 130: 1121–1131.
37. Lewis SM, Poon PP, Singer RA, Johnston GC, Spang A (2004) The ArfGAP
Glo3 is required for the generation of COPI vesicles. Mol Biol Cell 15:
4064–4072.
38. Pidoux AL, Armstrong J (1993) The BiP protein and the endoplasmic reticulum
of Schizosaccharomyces pombe: fate of the nuclear envelope during cell division. J Cell
Sci 105(Pt 4): 1115–1120.
39. Lu L, Ladinsky MS, Kirchhausen T (2009) Cisternal organization of the
endoplasmic reticulum during mitosis. Mol Biol Cell 20: 3471–3480.
40. Selmecki A, Forche A, Berman J (2006) Aneuploidy and isochromosome
formation in drug-resistant Candida albicans. Science 313: 367–370.
41. Selmecki AM, Dulmage K, Cowen LE, Anderson JB, Berman J (2009)
Acquisition of aneuploidy provides increased fitness during the evolution of
antifungal drug resistance. PLoS Genet 5: e1000705.
42. Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, et al. (2010) Aneuploidy
confers quantitative proteome changes and phenotypic variation in budding
yeast. Nature 468: 321–325.
43. Schindler C, Rodriguez F, Poon PP, Singer RA, Johnston GC, et al. (2009) The
GAP domain and the SNARE, coatomer and cargo interaction region of the
ArfGAP2/3 Glo3 are sufficient for Glo3 function. Traffic 10: 1362–1375.
44. Robinson M, Poon PP, Schindler C, Murray LE, Kama R, et al. (2006) The
Gcs1 Arf-GAP mediates Snc1,2 v-SNARE retrieval to the Golgi in yeast. Mol
Biol Cell 17: 1845–1858.
45. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR (2000) Urease as a
virulence factor in experimental cryptococcosis. Infect Immun 68: 443–448.
46. Williamson PR (1994) Biochemical and molecular characterization of the
diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol
176: 656–664.
47. Hua Z, Graham TR (2003) Requirement for neo1p in retrograde transport from
the Golgi complex to the endoplasmic reticulum. Mol Biol Cell 14: 4971–4983.
48. Havel VE, Wool NK, Ayad D, Downey KM, Wilson CF, et al. (2011) Ccr4
Promotes Resolution of the Endoplasmic Reticulum Stress Response during
Host Temperature Adaptation in Cryptococcus neoformans. Eukaryot Cell 10:
895–901.
49. Hong MP, Vu K, Bautos J, Gelli A (2010) Cch1 restores intracellular Ca2+ in
fungal cells during endoplasmic reticulum stress. J Biol Chem 285:
10951–10958.
50. Zhang S, Roche K, Nasheuer HP, Lowndes NF (2011) Modification of histones
by the sugar {beta}-N-acetylglucosamine (GlcNAc) occurs on multiple residues,
including H3 serine 10, and is cell cycle regulated. J Biol Chem.
51. Wang H, Spang A, Sullivan MA, Hryhorenko J, Hagen FK (2005) The terminal
phase of cytokinesis in the Caenorhabditis elegans early embryo requires protein
glycosylation. Mol Biol Cell 16: 4202–4213.
52. Anderson DJ, Hetzer MW (2008) Reshaping of the endoplasmic reticulum limits
the rate for nuclear envelope formation. J Cell Biol 182: 911–924.
53. Gonzalez Y, Meerbrey K, Chong J, Torii Y, Padte NN, et al. (2009) Nuclear
shape, growth and integrity in the closed mitosis of fission yeast depend on the
Ran-GTPase system, the spindle pole body and the endoplasmic reticulum.
J Cell Sci 122: 2464–2472.
54. Golden A, Liu J, Cohen-Fix O (2009) Inactivation of the C. elegans lipin homolog
leads to ER disorganization and to defects in the breakdown and reassembly of
the nuclear envelope. J Cell Sci 122: 1970–1978.
55. Schmitt HD (2010) Dsl1p/Zw10: common mechanisms behind tethering
vesicles and microtubules. Trends Cell Biol 20: 257–268.
56. Perfect JR, Ketabchi N, Cox GM, Ingram CW, Beiser CL (1993) Karyotyping
of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol 31:
3305–3309.
57. Kwon-Chung JK, Bennett JE (1992) Cryptococcosis. In: Kwon-Chung JK,
Bennett JE, eds. Medical Mycology. Pennsylvania: Lea & Febiger. pp 397–446.
58. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR (1993) Gene
transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol
175: 1405–1411.
59. Davidson RC, Cruz MC, Sia RA, Allen B, Alspaugh JA, et al. (2000) Gene
disruption by biolistic transformation in serotype D strains of Cryptococcus
neoformans. Fungal Genet Biol 29: 38–48.
60. Lengeler KB, Wang P, Cox GM, Perfect JR, Heitman J (2000) Identification of
the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa
strain thought to have been extinct. Proc Natl Acad Sci U S A 97: 14455–14460.
61. Yoneda A, Doering TL (2006) A eukaryotic capsular polysaccharide is
synthesized intracellularly and secreted via exocytosis. Mol Biol Cell 17:
5131–5140.
62. Rittershaus PC, Kechichian TB, Allegood JC, Merrill AH, Jr., Hennig M, et al.
(2006) Glucosylceramide synthase is an essential regulator of pathogenicity of
Cryptococcus neoformans. J Clin Invest 116: 1651–1659.
Chromosome 4 Disomy Formation in C. neoformans
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33022